Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 301 publications
Clinical Applications of Theranostics.
Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
Published: May 21, 2026
Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 02, 2026
Leading Through Change: Reflections from Jason Lewis.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 08, 2026
Minimal chemical modification enables alpha/beta radiolabeling of sacituzumab govitecan for targeted therapy in high grade serous ovarian cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 23, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.
Journal: JCO precision oncology
Published: November 20, 2025
Recent Developments in the Diagnosis and Treatment of Disseminated and Rare Melanoma with Radiotheranostics.
Journal: ACS pharmacology & translational science
Published: November 11, 2025
Delta-like Ligand 3-Directed 225Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer Models.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 24, 2025
Exploring the 89 Zr/ 177 Lu Theranostic Pairing with an Extracellular Matrix Targeted Radiopharmaceutical Against Triple Negative Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 11, 2025
Exploring the 89Zr/177Lu Theranostic Pairing with an Extracellular Matrix-Targeted Radiopharmaceutical against Triple-Negative Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 11, 2025
Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 28, 2025
Last Updated: 09/26/2026